BofA Upgrades Iqvia On Upside Potential


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Despite negative projections immediately following the Quintiles-IMS Holdings merger in 2016, Iqvia Holdings, Inc. (NYSE:IQV) is showing growth, according to Bank of America Merrill Lynch. 

The Analyst

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Analyst Derik de Bruin on Wednesday upgraded Iqvia Holdings from Neutral to Buy and increased the price target from $112 to $135.

The Thesis

"We believe that IQV will be able to grow competitively by leveraging its differentiated next-generation clinical development offerings and commercial technology solutions, with further potential growth upside through capital deployment,” de Bruin said in the upgrade note. 

Increased contract win rates and accelerating clinical development bookings account for much of the growth, the analyst said. 


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Most of these contracts were achieved through IQV’s new orchestrated customer engagement solution launched in 2017, de Bruin said. The new bookings should start contributing to revenue growth in 2019, he said. 

Iqvia has demonstrated willingness to use capital deployment via share repurchases in the event that growth targets are below expectations, according to BofA. 

"We are positive [on] IQV as the pharma and biotech end markets remain healthy," de Bruin said. 

Price Action

Iqvia shares were down 1.29 pecent at $120.45 at the close Friday. 

Related Links:

Uncertainty Around Iqvia's Near-Term Earnings Path Is Clearing, Goldman Sachs Says In Upgrade

KeyBanc: Iqvia Holdings' Valuation Might Be Overheated


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Posted In: Analyst ColorBiotechUpgradesPrice TargetAnalyst RatingsGeneralBank of America Merrill LynchDerik de Bruin